Protara Therapeutics (TARA) EPS (Basic): 2013-2014
Historic EPS (Basic) for Protara Therapeutics (TARA) over the last 2 years, with Dec 2014 value amounting to -$3.16.
- Protara Therapeutics' EPS (Basic) was N/A to $64.49 in Q4 2014 from the same period last year, while for Dec 2014 it was -$3.15, marking a year-over-year change of. This contributed to the annual value of -$3.16 for FY2014, which is 94.70% up from last year.
- According to the latest figures from FY2014, Protara Therapeutics' EPS (Basic) is -$3.16, which was up 94.70% from -$59.66 recorded in FY2013.
- Protara Therapeutics' EPS (Basic)'s 5-year high stood at -$3.16 during FY2014, with a 5-year trough of -$59.66 in FY2013.
- Moreover, its 2-year median value for EPS (Basic) was -$31.41 (2014), whereas its average is -$31.41.
- Data for Protara Therapeutics' EPS (Basic) shows a peak YoY spiked of 94.70% (in 2014) over the last 5 years.
- Protara Therapeutics' EPS (Basic) (Yearly) stood at -$59.66 in 2013, then skyrocketed by 94.70% to -$3.16 in 2014.